Search Results - Keisuke Ojiro

  • Showing 1 - 7 results of 7
Refine Results
  1. 1

    Continuation of atezolizumab plus bevacizumab beyond initial progressive disease: clinical benefits in patients with unresectable hepatocellular carcinoma – a multicenter cohort st... by Takaya Tabuchi, Nobuhito Taniki, Keisuke Ojiro, Keisuke Ojiro, Ryosuke Kasuga, Yukie Nakadai, Po-Sung Chu, Shingo Usui, Shunsuke Shiba, Toshiyuki Tahara, Hirokazu Komatsu, Yuriko Fujita, Fumihiko Kaneko, Hitomi Hoshi, Akihiro Yamaguchi, Seiichiro Fukuhara, Yukishige Okamura, Hideaki Kanamori, Hirotoshi Ebinuma, Masashi Tamura, Jitsuro Tsukada, Yasushi Hasegawa, Yuta Abe, Minoru Kitago, Masahiro Jinzaki, Yuko Kitagawa, Takanori Kanai, Nobuhiro Nakamoto

    Published in Frontiers in Immunology (2025-09-01)
    Get full text
    Article


  2. 2

    Effect of Telmisartan or Losartan for Treatment of Nonalcoholic Fatty Liver Disease: Fatty Liver Protection Trial by Telmisartan or Losartan Study (FANTASY) by Takumi Hirata, Kengo Tomita, Toshihide Kawai, Hirokazu Yokoyama, Akira Shimada, Masahiro Kikuchi, Hiroshi Hirose, Hirotoshi Ebinuma, Junichiro Irie, Keisuke Ojiro, Yoichi Oikawa, Hidetsugu Saito, Hiroshi Itoh, Toshifumi Hibi

    Published in International Journal of Endocrinology (2013-01-01)
    Get full text
    Article


  3. 3

    Erratum to “Effect of Telmisartan or Losartan for Treatment of Nonalcoholic Fatty Liver Disease: Fatty Liver Protection Trial by Telmisartan or Losartan Study (FANTASY)” by Takumi Hirata, Kengo Tomita, Toshihide Kawai, Hirokazu Yokoyama, Akira Shimada, Masahiro Kikuchi, Hiroshi Hirose, Hirotoshi Ebinuma, Junichiro Irie, Keisuke Ojiro, Yoichi Oikawa, Hidetsugu Saito, Hiroshi Itoh, Toshifumi Hibi

    Published in International Journal of Endocrinology (2014-01-01)
    Get full text
    Article


  4. 4

    CLIF‐C Organ Failure Score and Liver Volume Predict Prognosis in Steroid‐Treated Severe Acute Autoimmune Hepatitis by Akihiko Ikura, Po‐sung Chu, Nobuhiro Nakamoto, Keisuke Ojiro, Nobuhito Taniki, Aya Yoshida, Masahiro Shinoda, Rei Morikawa, Karin Yamataka, Fumie Noguchi, Hitomi Hoshi, Shingo Usui, Hirotoshi Ebinuma, Yuko Kitagawa, Hidetsugu Saito, Takanori Kanai

    Published in Hepatology Communications (2020-07-01)
    Get full text
    Article


  5. 5

    Liver Fibrosis Markers Improve Prediction of Outcome in Non‐Acetaminophen‐Associated Acute Liver Failure by Aya Ugamura, Po‐sung Chu, Nobuhiro Nakamoto, Nobuhito Taniki, Keisuke Ojiro, Taizo Hibi, Masahiro Shinoda, Hideaki Obara, Yohei Masugi, Akihiro Yamaguchi, Shunsuke Shiba, Rei Morikawa, Shingo Usui, Hirotoshi Ebinuma, Yuko Kitagawa, Hidetsugu Saito, Takanori Kanai

    Published in Hepatology Communications (2018-11-01)
    Get full text
    Article


  6. 6

    On-treatment decrease of NKG2D correlates to early emergence of clinically evident hepatocellular carcinoma after interferon-free therapy for chronic hepatitis C. by Po-Sung Chu, Nobuhiro Nakamoto, Nobuhito Taniki, Keisuke Ojiro, Takeru Amiya, Yuko Makita, Hiroko Murata, Akihiro Yamaguchi, Shunsuke Shiba, Rei Miyake, Tadashi Katayama, Aya Ugamura, Akihiko Ikura, Karin Takeda, Hirotoshi Ebinuma, Hidetsugu Saito, Takanori Kanai

    Published in PLoS ONE (2017-01-01)
    Get full text
    Article


  7. 7

    Multiple asynchronous recurrence as a predictive factor for refractoriness against locoregional and surgical therapy in patients with intermediate-stage hepatocellular carcinoma by Ryosuke Kasuga, Nobuhito Taniki, Po-Sung Chu, Masashi Tamura, Takaya Tabuchi, Akihiro Yamaguchi, Shigeo Hayatsu, Jun Koizumi, Keisuke Ojiro, Hitomi Hoshi, Fumihiko Kaneko, Rei Morikawa, Fumie Noguchi, Karin Yamataka, Shingo Usui, Hirotoshi Ebinuma, Osamu Itano, Yasushi Hasegawa, Yuta Abe, Minoru Kitago, Masanori Inoue, Seishi Nakatsuka, Masahiro Jinzaki, Yuko Kitagawa, Takanori Kanai, Nobuhiro Nakamoto

    Published in Scientific Reports (2024-05-01)
    Get full text
    Article


Search Tools: